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Associations between smoking and variables
Characteristics of the population
Age (years, median [p25-p75])
Male sex (%)
Diabetes mellitus (%)
Killip class 2 (%)
Left ventricular ejection fraction (%, mean [±SD ])
Creatinine kinase peak (MU/L, median [p25-p75])
Intra-aortic balloon pump use (%)
Three-vessel coronary disease (%)
Final TIMI flow<3 (%)
Previous use of statins (%)
Hypertension (%)
Systolic Blood Pressure at admittance median [p25-
Diastolic Blood Pressure at admittance median [p25
Heart rate at admittance median [p25-p75])
List of abbreviations: TIMI ¼ thrombosis in myocardia
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patientsCigarette smoking is an established risk factor for coronary ar-
tery disease, known to be associated with an increased chronic
inflammatory state;1-2 nevertheless, it has been associated with
a better prognosis in the setting of acute coronary syndromes
in several studies.3-4 This phenomenon, (“smoker's paradox”)
has several potential explanations including the lower platelet
reactivity observed in smokers, irrespective of the type of
P2Y12 inhibitor drug used.5 Moreover, a higher inflammatory sta-
tus has been shown to increase platelet reactivity in patients
with acute coronary syndromes.6 As acute inflammation plays a
key role in the pathophysiology of STEMI, contributing to micro-
vascular dysfunction,7-8 we sought to assess whether it could be
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0.1016/j.hjc.2019.03.004nalyzed a large single-center cohort of 2958 consecutive
with STEMI treated by pPCI during 2005-2017 in our Uni-
versity Hospital. The inflammatory response was evaluated using
an established acute inflammatory index, Neutrophil-to-
Lymphocyte Ratio (NLR), calculated the first day after reperfusion.9
Microvascular reperfusion was assessed using ST resolution (STR),
defined according to previous literature.10 Continuous variables
were expressed as median [p25%-p75%] and compared by the
Mann-Whitney test, whereas categorical variables were expressed
as percentages and compared by the Fisher exact test. Mortality
analysis was performed by generating Kaplan-Meier curves and lo-
gistic regression models.
Overall, 62.9% of our population were smokers; they were
younger, more frequently men and less frequently diabetics and hy-
pertensive, and had a lower CK peak (all p < 0.001, see Table 1). Sys-
tolic blood pressure did not show significant difference in smokers
at admission, while diastolic blood pressure and heart rate were
statistically higher (80 [70-95] vs. 80 [70-90] mmHg, p ¼ 0.003
and 76 [66-88] vs. 75 [65-86] bpm, p ¼ 0.006, respectively). ST res-
olution occurred more frequently in smokers: 72.5% vs. 65.2%
(p ¼ 0.001) and NLR was lower in smokers: 4.6 [2.6-7.7] vs 5.1
[2.8-8.5] (p < 0.001). In the whole population, all-cause mortality
was 4.5% in hospital and 5.4% at 30 days. Thirty-day mortality
was higher in nonsmokers than in smokers (10% vs. 2.5%,
p < 0.001) [see Figure 1]. The association of previous smoking
with a better prognosis was confirmed at multivariable analysisking p-value
¼ 37.2%) Yes (n ¼ 62.8%)
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Figure 1. Kaplan-Meier curves for 30-day survival.
Letter to the Editor / Hellenic Journal of Cardiology xxx (xxxx) xxx2for all cause 30-day mortality (adjusted for sex, diabetes, baseline
eGFR, age, Killip class 2, three-vessel disease, CK peak, and basal
hemoglobin), with a protective hazard ratio of 0.55 [95% CI 0.33-
0.91, p ¼ 0.019].
In conclusion, our analysis showed that among patients with
STEMI treated by pPCI, smokers showed a decreased acute inflam-
matory response, confirming previous data,4 and a lower degree of
microvascular dysfunction, two phenomena potentially associated
with lower mortality. Accordingly, we found a significant associa-
tion between smoking and lower short-term mortality, both at
univariate and multivariable analyses, confirming the existence
of a smoker's paradox in our population. Because of the retrospec-
tive and epidemiological nature of the study, we cannot exclude
the presence of selection bias or confounding/reporting bias;
another limitation is the lack of data on platelet reactivity in the
present cohort. Despite this, we hypothesize that the chronic in-
flammatory status due to smoking2 could play a protective role
in the acute inflammatory setting of a STEMI, providing a sort of
“inflammatory preconditioning,” thereby reducing the activation
of platelets and chemotaxis of inflammatory cells in coronary cap-
illaries and the degree of microvascular dysfunction. Further
studies assessing the interaction between acute inflammatory
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